Chalkiadakis G, Wihlm JM, Morand G. Primary malignant melanoma of the esophagus. Ann Thorac Surg. 1985;39:472–5.

Article  CAS  PubMed  Google Scholar 

Li B, Lei W, Shao K, et al. Characteristics and prognosis of primary malignant melanoma of the esophagus. Melanoma Res. 2007;17:239–42.

Article  PubMed  Google Scholar 

Cazzato G, Cascardi E, Colagrande A, et al. The thousand faces of malignant melanoma: a systematic review of the primary malignant melanoma of the esophagus. Cancers (Basel). 2022;14:3725.

Article  PubMed  Google Scholar 

Li J, Guan W, Ren W, et al. Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus. Neoplasia. 2022;30:100811.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun H, Gong L, Zhao G, et al. Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus. J Surg Oncol. 2018;117:588–96.

Article  PubMed  Google Scholar 

Iwanuma Y, Tomita N, Amano T, et al. Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis. J Gastroenterol. 2012;47:21–8.

Article  PubMed  Google Scholar 

Sabanathan S, Eng J, Pradhan GN. Primary malignant melanoma of the esophagus. Am J Gastroenterol. 1989;84:1475–81.

CAS  PubMed  Google Scholar 

Hashimoto T, Makino T, Yamasaki M, et al. Clinicopathological characteristics and survival of primary malignant melanoma of the esophagus. Oncol Lett. 2019;18:1872–80.

CAS  PubMed  PubMed Central  Google Scholar 

Gao S, Li J, Feng X, et al. Characteristics and surgical outcomes for primary malignant melanoma of the esophagus. Sci Rep. 2016;6:23804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai L, Wang ZM, Xue ZQ, et al. Results of surgical treatment for primary malignant melanoma of the esophagus: a multicenter retrospective study. J Thorac Cardiovasc Surg. 2020;S0022–5223:30571–7.

Google Scholar 

Makuuchi H, Takubo K, Yanagisawa A, et al. Esophageal malignant melanoma: analysis of 134 cases collected by the Japan Esophageal Society. Esophagus. 2015;12:158–69.

Article  Google Scholar 

Kuwabara S, Ebihara Y, Nakanishi Y, et al. Primary malignant melanoma of the esophagus treated with subtotal esophagectomy: a case report. BMC Surg. 2017;17:122.

Article  PubMed  PubMed Central  Google Scholar 

Wolchok J, Chiarion-Sileni V, Gonzalez R, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377:1345–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hodi FS, Chiarion-Sileni V, Gonzalez R, et al. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19:1480–92.

Article  CAS  PubMed  Google Scholar 

Sasaki K, Uchikado Y, Omoto I, et al. Multidisciplinary therapy for metastatic primary malignant melanoma of the esophagus: a case repor. Mol Clin Oncol. 2018;8:528–32.

PubMed  PubMed Central  Google Scholar 

Inadomi K, Kumagai H, Arita S, et al. Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: a case report. Medicine (Baltimore). 2016;95:e4283.

Article  PubMed  Google Scholar 

Endo F, Akiyama Y, Onishi M, et al. Primary esophageal malignant melanoma successfully treated with retroperitoneal recurrence after esophagectomy: a case report. Int J Surg Case Rep. 2020;75:152–6.

Article  PubMed  PubMed Central  Google Scholar 

Takahashi A, Namikawa K, Ogata D, et al. Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma. J Dermatol. 2023;50:525–35.

Article  CAS  PubMed  Google Scholar 

Watson AS, Goutam S, Stukalin I et al. Association of immune-related adverse events, hospitalization, and therapy resumption with survival among patients with metastatic melanoma receiving single-agent or combination immunotherapy. JAMA Netw Open. 2022;1;5(12).

Attlassy N, Agbeh A, Patnaik R, et al. Primary malignant melanoma of the gastroesophageal junction treated with immunotherapy: a case report. WMJ. 2023;122:77–80.

PubMed  Google Scholar 

Nambara S, Sakaguchi Y, Tsuda Y, et al. Primary esophageal malignant melanoma without recurrence after surgery and adjuvant therapy with nivolumab. Int Cancer Conf J. 2022;12:100–3.

Article  PubMed  PubMed Central  Google Scholar 

Ho K, Hirata Y, Egawa T. A case of thoracoscopic subtotal esophagectomy for malignant esophageal melanoma. Gan To Kagaku Ryoho. 2023;50:65–8.

PubMed  Google Scholar 

Hanada K, Tsunoda S, Nomura M, et al. A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus. Surg Case Rep. 2022;8:206.

Article  PubMed  PubMed Central  Google Scholar 

Minagawa Y, Tanaka Y, Funatsuya T, et al. Successful postoperative recurrence treatment of malignant melanoma of the esophagus by anti-PD-1 and anti-CTLA-4 combined therapy—a case report. Gan To Kagaku Ryoho. 2022;49:1160–2.

PubMed  Google Scholar 

Kashfi S, Marneni N, Sharma S, et al. Primary malignant melanoma of the esophagus in a 76-year-old female. Cureus. 2022;14:e23250.

PubMed  PubMed Central  Google Scholar 

Furune S, Kondo C, Takano Y, et al. Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment. Int Cancer Conf J. 2021;11:46–8.

Article  PubMed  PubMed Central  Google Scholar 

Yamaguchi T, Fushida S, Kinoshita J, et al. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration. Surg Case Rep. 2021;7:253.

Article  PubMed  PubMed Central  Google Scholar 

Tsukamoto R, Ihara H, Takase M, et al. Immunotherapy against esophageal primary amelanotic malignant melanoma relapse. J Surg Case Rep. 2021;13:10.

Google Scholar 

Okamoto T, Nakano E, Yamauchi T. Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report. J Med Case Rep. 2021;15:345.

Article  PubMed  PubMed Central  Google Scholar 

Ito S, Tachimori Y, Terado Y, et al. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report. J Med Case Rep. 2021;15:237.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Kong Y, Chi Z, et al. Primary malignant melanoma of the esophagus: a retrospective analysis of clinical features, management, and survival of 76 patients. Thorac Cancer. 2019;10:950–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumoto Y, Hirasawa S, Natsume T, et al. A case of primary amelanotic malignant melanoma of the esophagus, wherein pseudoprogression was suspected during immune checkpoint inhibitor treatment. Gan To Kagaku Ryoho. 2020;47:1251–3.

PubMed  Google Scholar 

Yamai D, Ichikawa H, Kano Y, et al. A case of esophageal primary malignant melanoma that developed during the follow-up of esophageal melanocytosis. Gan To Kagaku Ryoho. 2019;46:2012–4.

PubMed  Google Scholar 

Rochefort P, Roussel J, de la Fouchardière A, et al. Primary malignant melanoma of the esophagus, treated with immunotherapy: a case report. Immunotherapy. 2018;10:831–5.

Article  CAS  PubMed  Google Scholar